Piotr Wieczorek

Piotr Wieczorek

Auto-generated profile, based on publicly available information

Piotr Wieczorek

Department of Microbiological Diagnostics and Infectious Immunology, Medical University of Bialystok, Bialystok, Poland

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2008 in Folia Histochemica et Cytobiologica
Verified
Journal Article
Open access
PDF file
PWPiotr Wieczorek
Piotr Wieczorek
PSPaweł Sacha
Paweł Sacha
THTomasz Hauschild
Tomasz Hauschild
MZMarcin Zórawski
Marcin Zórawski
MKMałgorzata Krawczyk
Małgorzata Krawczyk
ETElżbieta Anna Tryniszewska
Elżbieta Anna Tryniszewska
Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.

18 April 2012 in Molecules
Verified
Journal Article
Open access
PDF file
Katarzyna WinnickaKatarzyna Winnicka
Katarzyna Winnicka
Magdalena WróblewskaMagdalena Wróblewska
Magdalena Wróblewska
PWPiotr Wieczorek
Piotr Wieczorek
PSPaweł Sacha
Paweł Sacha
ETElżbieta Anna Tryniszewska
Elżbieta Anna Tryniszewska
Ketoconazole (KET), an imidazole derivative with well-known antifungal properties, is lipophilic and practically insoluble in water, therefore its clinical use has some practical disadvantages. The aim of the present study was to investigate the influence of PAMAM-NH2 and PAMAM-OH dendrimers generation 2 and generation 3 on the solubility and antifungal activity of KET and to design and evaluate KET hydrogel with PAMAM dendrimers. It was shown that the surface charge of PAMAM dendrimers strongly affects their influence on the improvement of solubility and antifungal activity of KET. The MIC and MFC values obtained by broth dilution method indicate that PAMAM-NH2 dendrimers significantly (up to 16-fold) increased the antifungal activity of KET against Candida strains (e.g., in culture Candida albicans 1103059/11 MIC value was 0.008 μg/mL and 0.064 μg/mL, and MFC was 2 μg/mL and 32 μg/mL for KET in 10 mg/mL solution of PAMAM-NH2 G2 and pure KET, respectively). Antifungal activity of designed KET hydrogel with PAMAM-NH2 dendrimers measured by the plate diffusion method was definitely higher than pure KET hydrogel and than commercial available product. It was shown that the improvement of solubility and in the consequence the higher KET release from hydrogels seems to be a very significant factor affecting antifungal activity of KET in hydrogels containing PAMAM dendrimers.

22 July 2013 in Molecules
Verified
Journal Article
Open access
PDF file
Katarzyna WinnickaKatarzyna Winnicka
Katarzyna Winnicka
Magdalena WróblewskaMagdalena Wróblewska
Magdalena Wróblewska
PWPiotr Wieczorek
Piotr Wieczorek
PSPaweł Sacha
Paweł Sacha
ETElżbieta Anna Tryniszewska
Elżbieta Anna Tryniszewska
Erythromycin (EM) and tobramycin (TOB) are well-known and widely used antibiotics, belonging to different therapeutic groups: macrolide and aminoglycoside, respectively. Moreover, they possess different solubility: EM is slightly soluble and TOB is freely soluble in water. It was previously demonstrated that PAMAM dendrimers enhanced the pharmacological activity of antifungal drugs by increasing their solubility. Therefore, it appears interesting to investigate the effect of PAMAM-NH2 and PAMAM-OH dendrimers generation 2 (G2) and generation 3 (G3) on the antibacterial activity of antibiotics with different water solubility. In this study it was shown that the aqueous solubility of EM was significantly increased by PAMAM dendrimers (PAMAM-NH2 and PAMAM-OH caused about 8- and 7- fold solubility increases, respectively). However, it was indicated that despite the increase in the solubility, there was only slight influence on the antibacterial activity of EM (2- and 4- fold decreases in the MBC values of EM in the presence of PAMAM-OH G3 and PAMAM-NH2 G2 or G3 for strains of Staphylococcus aureus were noted, respectively). It was also found that there was no influence of PAMAM on the antibacterial activity of hydrophilic TOB.

23 December 2016 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
PMPiotr Majewski
Piotr Majewski
PWPiotr Wieczorek
Piotr Wieczorek
DODominika Ojdana
Dominika Ojdana
ASAnna Sieńko
Anna Sieńko
OKOksana Kowalczuk
Oksana Kowalczuk
ETElżbieta Anna Tryniszewska
Elżbieta Anna Tryniszewska
The growing incidence of multidrug-resistant (MDR) bacteria is an emerging challenge in modern medicine. The utility of carbapenems, considered “last-line” agents in therapy of infections caused by MDR pathogens, is being diminished by the growing incidence of various resistance mechanisms. Enterobacter cloacae have lately begun to emerge as an important pathogen prone to exhibiting multiple drug resistance. We aimed to investigate the molecular basis of carbapenem-resistance in 44 E. cloacae clinical strains resistant to at least one carbapenem, and 21 susceptible strains. Molecular investigation of 65 E. cloacae clinical strains was based on quantitative polymerase chain reaction (qPCR) allowing for amplification of ampC, ompF, and ompC transcripts, and analysis of nucleotide sequences of alleles included in MLST scheme. Co-operation of three distinct carbapenem resistance mechanisms has been reported—production of OXA-48 (5%), AmpC overproduction (97.7%), and alterations in outer membrane (OM) transcriptome balance. Carbapenem-resistant E. cloacae were characterized by (1.) downregulation of ompF gene (53.4%), which encodes protein with extensive transmembrane channels, and (2.) the polarization of OM transcriptome-balance (79.1%), which was sloped toward ompC gene, encoding proteins recently reported to possess restrictive transmembrane channels. Subpopulations of carbapenem-susceptible strains showed relatively high degrees of sequence diversity without predominant types. ST-89 clearly dominates among carbapenem-resistant strains (88.6%) suggesting clonal spread of resistant strains. The growing prevalence of pathogens resistant to all currently available antimicrobial agents heralds the potential risk of a future “post-antibiotic era.” Great efforts need to be taken to explore the background of resistance to “last resort” antimicrobials.

4 June 2008 in Folia Histochemica et Cytobiologica
Verified
Journal Article
Open access
PDF file
PSPaweł Sacha
Paweł Sacha
PWPiotr Wieczorek
Piotr Wieczorek
THTomasz Hauschild
Tomasz Hauschild
MZMarcin Zórawski
Marcin Zórawski
DODorota Olszańska
Dorota Olszańska
ETElżbieta Anna Tryniszewska
Elżbieta Anna Tryniszewska
Metallo-beta-lactamases of Pseudomonas aeruginosa--a novel mechanism resistance to beta-lactam antibiotics.

1 March 2018 in Advances in Medical Sciences
Verified
Journal Article
Closed access
DODominika Ojdana
Dominika Ojdana
ASAnna Sieńko
Anna Sieńko
PSPaweł Sacha
Paweł Sacha
PMPiotr Majewski
Piotr Majewski
PWPiotr Wieczorek
Piotr Wieczorek
ETElżbieta Anna Tryniszewska
Elżbieta Anna Tryniszewska